Growth Metrics

Immuron (IMRN) Share-based Compensation (IS) (2017 - 2023)

Immuron's quarterly Share-based Compensation (IS) came in at $2.0 million in Q3 2023, up 1249.86% quarter-over-quarter from $151687.1 in Q2 2023.

Immuron has reported Share-based Compensation (IS) for 6 years, with the latest figure at $2.0 million in Q3 2023.

  • For the quarter ending Q3 2023, Share-based Compensation (IS) changed N/A year-over-year to $2.0 million; the trailing twelve-month figure through Sep 2023 stood at $2.0 million (changed N/A YoY), and the FY2023 full-year result was $2.0 million, changed N/A from the prior year.
  • Share-based Compensation (IS) for Q3 2023 stood at $2.0 million, up from $151687.1 in the prior quarter.
  • The five-year high for Share-based Compensation (IS) was $2.0 million in Q3 2023, with the low at -$42.7 billion in Q4 2021.
  • Average Share-based Compensation (IS) over 5 years is -$5.3 billion, with a median of $109827.2 recorded in 2023.
  • Year-over-year, Share-based Compensation (IS) sank 201692833.78% in 2021 and jumped 123.18% in 2023.
  • Tracing IMRN's Share-based Compensation (IS) over 5 years: stood at $6070.0 in 2019, then sank by 448.6% to -$21160.1 in 2020, then slumped by 201692833.78% to -$42.7 billion in 2021, then jumped by 100.0% to $2.0 million in 2022, then climbed by 2.07% to $2.0 million in 2023.
  • The last three Share-based Compensation (IS) figures came in at $2.0 million (Q3 2023), $151687.1 (Q2 2023), and $2.0 million (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (IS) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.45 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 14.90 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Immuron 1.27 Bn 1.27 Bn - -

Historic Data

Download Data 🔒
DateValue
Sep 28, 2023 2.05 Mn
Sep 28, 2023 2.05 Mn
Jun 30, 2023 151,687.08
Jun 30, 2023 151,687.08
Dec 31, 2022 2.01 Mn
Dec 31, 2022 2.01 Mn
Jun 30, 2022 67,967.42
Jun 30, 2022 67,967.42
Dec 31, 2021 -42.68 Bn
Dec 31, 2021 -42.68 Bn
Jun 30, 2021 1.63 Mn
Jun 30, 2021 1.63 Mn
Dec 31, 2020 -21,160.13
Dec 31, 2020 -21,160.13
Dec 31, 2019 6,070.00
Dec 31, 2019 6,070.00
Dec 31, 2017 -46,380.23
Dec 31, 2017 -46,380.23